The regional government of Castilla-La Mancha urged people at an event in Guadalajara to take part in organised breast cancer screening. The Junta’s delegate, Rosa María García, gave current figures for the province: around 140 cases of breast cancer were diagnosed in Guadalajara each year; in 2025, more than 12,300 women took part in the Screening-Programm programme, and 65 of them were referred for further diagnostic tests. The figures come from an official statement by the Junta de Comunidades de Castilla-La Mancha.
The event brought together specialists, patients and family members, and included the account of a man with breast cancer. Alongside awareness and prevention, advances in diagnosis were a central focus. The regional government points to investment in new biopsy tables and modern imaging techniques to improve the quality of examinations and reduce waiting times. At hospitals in Guadalajara, multidisciplinary committees coordinate care, so that findings can be assessed promptly and treatment decisions agreed. The Hospital Universitario de Guadalajara highlights the importance of this case-by-case coordination in treatment.
The background is a Spain-wide revision of public recommendations on mammography screening by the Ministerio de Sanidad. The authorities are working to expand the programme and define its target groups more precisely, so that risk profiles are better taken into account. Castilla-La Mancha points to high participation rates in its programmes and says invitations and follow-up are continually being improved.
Patient organisations welcome systematic early detection but are calling for further steps. These include greater involvement of younger at-risk groups, clearer time targets between an initial finding and diagnosis, and expanded psychosocial follow-up care. These demands should be distinguished from the regional government’s official information, which primarily describes the current situation and recent investment.
The figures presented for Guadalajara underline the programme’s importance for early tumour detection. It remains unclear how far the recent purchases will speed up diagnosis in practice and whether the proportion of tumours detected early will measurably increase. Meaningful trend data for 2026 and 2027 will provide clarity only later. Until then, the Junta de Comunidades de Castilla-La Mancha is relying on broad-based information and consistent participation in the screening programme to improve chances of recovery and avoid invasive treatment wherever possible.
Editor: Mira Cadena (Article created with AI assistance).